Glycyrrhetinic acid improves inflammation and corneal injury induced by Pseudomonas aeruginosa by inhibiting GSDMD mediated atypical cell pyroptosis
TANG Ying1, LI Pengfei2, YU Jinjin1
1. Department of Ophthalmology, Wuxi Hospital of Traditional Chinese Medicine, Wuxi 214000, China; 2. Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong 226000, China
Abstract:Objective To investigate how glycyrrhetinic acid improves inflammation and corneal injury induced by Pseudomonas aeruginosa by inhibiting Gasdermin-D (GSDMD) mediated atypical cell pyroptosis. Methods Prepare a rat model of Pseudomonas aeruginosa keratitis and randomly divide the rats into a control group, PA group, and GLY+PA group. Compare the keratitis index of each group; Enzyme linked immunosorbent assay (ELISA) was used to detect serum inflammatory factors; Hematoxylin eosin (HE) staining was used to detect pathological changes in corneal tissue; Immunofluorescence detection showed positive expression of caspase-11 and GSDMD in corneal tissue for cysteine; Protein blotting and qRT PCR were used to detect the expression of caspase-4, caspase-5, caspase-11, GSDMD protein, and mRNA in corneal tissue. Results The keratitis index and serum levels of interleukin-1β (IL-1 β) (78.54±8.03) and interleukin-18(IL-18) (26.31±2.74), inflammatory cell density, percentage of positive expression areas of caspase-11 and GSDMD, as well as the expression of caspase-4, caspase-5, caspase-11, GSDMD protein and mRNA in corneal tissue of rats in the PA group were significantly higher than those in the control group; Compared with the PA group, the GLY+PA group significantly reduced the keratitis index and serum levels of IL-1β (46.27±5.11) and IL-18(13.52±1.46), inflammatory cell density, percentage of positive expression areas of caspase-11 and GSDMD, as well as the expression of caspase-4, caspase-5, caspase-11, GSDMD protein and mRNA in corneal tissue. Conclusion Glycyrrhizic acid inhibits the corneal inflammatory response and tissue damage in rats with Pseudomonas aeruginosa keratitis, and its mechanism of action may be related to the inhibition of GSDMD-mediated activation of the atypical cellular pyroptosis pathway.
[1] BAI Y, HU Y, GAO Y, et al.Oxygen self-supplying nanotherapeutic for mitigation of tissue hypoxia and enhanced photodynamic therapy of bacterial keratitis[J]. ACS Appl Mater Interfaces, 2021, 13(29): 33790-33801. [2] JIAN HJ, ANAND A, LAI JY, et al.In situ hybridization of polymeric curcumin to arginine-derived carbon quantum dots for synergistic treatment of bacterial infections[J]. ACS Appl Mater Interfaces, 2023, 15(22): 26457-26471. [3] SHOJI MK, GUTKIND NE, MEYER BI, et al.Multidrug-resistant pseudomonas aeruginosa keratitis associated with artificial tear use[J]. JAMA Ophthalmol, 2023, 141(5): 499-500. [4] SUZUKI T, INOUE H.Mechanisms underlying contact lens-related keratitis caused by pseudomonas aeruginosa[J]. Eye Contact Lens, 2022, 48(3): 134-137. [5] GU L, LIN J, WANG Q, et al.Dimethyl fumarate ameliorates fungal keratitis by limiting fungal growth and inhibiting pyroptosis[J]. Int Immunopharmacol, 2023, 115: 109721. [6] 刘可欣, 李志坚, 刘翔宇. GSDMD介导的细胞焦亡在眼科疾病中的研究进展[J]. 眼科新进展, 2021, 41(11): 1085-1088+1096. [7] LIAN H, FANG X, LI Q, et al.NLRP3 inflammasome-mediated pyroptosis pathway contributes to the pathogenesis of candida albicans keratitis[J]. Front Med (Lausanne), 2022, 9: 845129. [8] ZHU K, ZHU X, LIU S, et al.Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting ferroptosis and neuroinflammation in neonatal rats via the HMGB1/GPX4 pathway[J]. Oxid Med Cell Longev, 2022, 2022: 8438528. [9] RAYAMAJHEE B, WILLCOX M, HENRIQUEZ FL, et al.The role of naturally acquired intracellular Pseudomonas aeruginosa in the development of Acanthamoeba keratitis in an animal model[J]. PLoS Negl Trop Dis, 2024, 18(1): e0011878. [10] 任越磊, 姜艳. 甘草甜素抑制HMGB1/RAGE信号通路对细菌性脑膜炎大鼠神经损伤的影响[J]. 中国病原生物学杂志, 2023, 18(10): 1122-1126. [11] YANG JJ, TSUEI KC, SHEN EP.The role of Type III secretion system in the pathogenesis of Pseudomonas aeruginosa microbial keratitis[J]. Tzu Chi Med J, 2021, 34(1): 8-14. [12] CAMPOLO A, PIFER R, SHANNON P, et al.Microbial adherence to contact lenses and pseudomonas aeruginosa as a model organism for microbial keratitis[J]. Pathogens, 2022, 11(11): 1383. [13] GAO N, ME R, YU FX.Diabetes Exacerbates pseudomonas aeruginosa keratitis in streptozotocin-induced and db/db mice via altering programmed cell death pathways[J]. Invest Ophthalmol Vis Sci, 2023, 64(7): 14. [14] KATE A, BAGGA B, PONNAPATI LP, et al.Clinico-microbiological features and treatment outcomes of serratia keratitis and comparison with pseudomonas aeruginosa keratitis[J]. Ocul Immunol Inflamm, 2023, 31(3): 515-519. [15] KHAN U, KARMAKAR BC, BASAK P, et al.Glycyrrhizin, an inhibitor of HMGB1 induces autolysosomal degradation function and inhibits helicobacter pylori infection[J]. Mol Med, 2023, 29(1): 51. [16] 高嘉豪, 乔彦杰, 朱妍, 等. 甘草酸对脂多糖应激黄羽肉仔鸡抗炎性能的影响[J]. 畜牧兽医科学 (电子版), 2022(13): 14-17. [17] 黄盼, 王志鹏, 肖琛闻, 等. 甘草甜素对铜绿假单胞菌生物被膜形成的抑制作用[J]. 农业生物技术学报, 2022, 30(3): 570-579. [18] MINNS MS, LIBORO K, LIMA TS, et al.NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected neutrophils and regulates corneal disease severity[J]. Nat Commun, 2023, 14(1): 5832. [19] KROKEN AR, KLEIN KA, MITCHELL PS, et al.Intracellular replication of Pseudomonas aeruginosa in epithelial cells requires suppression of the caspase-4 inflammasome[J]. mSphere, 2023, 8(5): e0035123. [20] XU S, LIU X, LIU X, et al.Wedelolactone ameliorates pseudomonas aeruginosa-induced inflammation and corneal injury by suppressing caspase-4/5/11/GSDMD-mediated non-canonical pyroptosis[J]. Exp Eye Res, 2021, 211: 108750.